PUBLISHER: The Business Research Company | PRODUCT CODE: 1939188
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939188
Acellular dermal matrices (ADMs) are natural materials derived from skin tissue that undergo processing to remove all cellular components. These materials are utilized in surgical procedures to repair or replace damaged tissues. Serving as a scaffold, ADMs promote the growth and healing of new tissue. They are commonly used in procedures such as breast reconstruction and wound healing to support the regeneration of skin and soft tissues.
The primary types of acellular dermal matrices include human acellular dermal matrices, porcine acellular dermal matrices, and other source-derived acellular dermal matrices. Human acellular dermal matrices (HADMs) are biomaterials obtained from donated human skin, with all cellular components removed, leaving behind a collagen-rich structure that aids in tissue regeneration during reconstructive and surgical procedures. These products are distributed through various channels, such as direct sales, online platforms, and distributor networks. They are employed in a range of applications, including breast reconstruction, dental surgery, orthopedic surgery, wound care, and other medical procedures, with end users including hospitals, ambulatory surgical centers, specialty clinics, and research laboratories.
Tariffs are influencing the acellular dermal matrices market by increasing costs of imported biologic raw materials, processing equipment, sterilization systems, and cold-chain logistics components. Hospitals and specialty surgical centers in North America and Europe are most affected due to reliance on imported ADM products, while Asia-Pacific faces pricing pressure on export-oriented production. These tariffs are raising procedure costs and impacting procurement budgets. However, they are also encouraging local tissue processing facilities, regional manufacturing expansion, and investment in alternative biologic and composite dermal matrix technologies.
The acellular dermal matrices market research report is one of a series of new reports from The Business Research Company that provides acellular dermal matrices market statistics, including acellular dermal matrices industry global market size, regional shares, competitors with a acellular dermal matrices market share, detailed acellular dermal matrices market segments, market trends and opportunities, and any further data you may need to thrive in the acellular dermal matrices industry. This acellular dermal matrices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The acellular dermal matrices market size has grown strongly in recent years. It will grow from $1.61 billion in 2025 to $1.77 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increasing volume of reconstructive surgeries, rising incidence of chronic wounds, growing use of biomaterials in surgery, advancements in tissue processing techniques, expanding cosmetic and plastic surgery demand.
The acellular dermal matrices market size is expected to see strong growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine solutions, rising adoption of advanced wound care products, expansion of minimally invasive surgical procedures, growing focus on faster healing outcomes, increasing clinical acceptance of biologic implants. Major trends in the forecast period include increasing adoption of adms in reconstructive surgeries, rising use of biologic scaffolds in wound care, growing preference for ready-to-use dermal matrices, expansion of adm applications in orthopedic procedures, enhanced focus on biocompatibility and healing outcomes.
The rising number of chronic wounds is expected to significantly drive the growth of the acellular dermal matrices market in the coming years. Chronic wounds are injuries or sores that either heal very slowly or do not heal at all, often recurring and requiring specialized treatment. The growing prevalence of these wounds is closely linked to the increasing number of individuals with diabetes. Diabetes can impair blood circulation and damage nerves, making it more difficult for the body to heal even minor cuts, which can then develop into serious and persistent wounds. Acellular dermal matrices assist in managing chronic wounds by serving as a supportive scaffold that promotes natural tissue regeneration and speeds up the healing process. For example, in July 2023, OSF HealthCare, a nonprofit healthcare organization based in the U.S., reported that 6.7 million people in the country are currently affected by chronic wounds, with this number projected to grow by 2% annually over the next ten years. Therefore, the increasing prevalence of chronic wounds is fueling the expansion of the acellular dermal matrices market.
Leading companies in the acellular dermal matrices market are focusing on product innovation by developing dual-sided grafts to improve surgical versatility and ease of use. Dual-sided acellular dermal matrices are advanced grafts designed with two functional surfaces, allowing for more flexible implantation and streamlined handling during surgery. For instance, in May 2023, AlloSource, a U.S.-based nonprofit organization that supplies allografts derived from human tissue for medical procedures, introduced AlloMend Duo Acellular Dermal Matrix (ADM). This product is designed specifically for soft tissue reconstruction, offering surgeons a dependable option for restoring and reinforcing soft tissue defects. The deep reticular dermal allograft is engineered to integrate well with surrounding tissues, providing a scaffold that encourages cellular repopulation and the regeneration of native tissue.
In March 2023, Aziyo Biologics, a U.S.-based regenerative medicine company, entered into a partnership with Sientra Inc. to broaden access to biologic solutions for soft tissue reconstruction. This collaboration focuses on increasing the availability of SimpliDerm, an acellular dermal matrix, to support procedures such as breast reconstruction. The initiative is aimed at improving access to biologic products for women undergoing reconstructive surgery. Sientra Inc. is a U.S.-based medical aesthetics company that produces silicone breast implants and other products for cosmetic and reconstructive breast procedures.
Major companies operating in the acellular dermal matrices market are Stryker Corporation, Smith & Nephew plc, ConvaTec Group plc, Integra LifeSciences Corporation, Gunze Limited, MTF Biologics, Organogenesis Inc., RTI Surgical Holdings Inc., LifeNet Health, HANS BIOMED, PolyNovo Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, CG Bio Inc., Meccellis Biotech, Aziyo Biologics Inc., MiMedx Group Inc., Axogen Inc., AlloSource, Kerecis Ltd.
North America was the largest region in the acellular dermal matrices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acellular dermal matrices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the acellular dermal matrices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The acellular dermal matrices market includes sales of xenogeneic acellular dermal matrices, collagen-based acellular dermal matrices, bi-layered acellular dermal matrices, and dermal substitute products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Acellular Dermal Matrices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses acellular dermal matrices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for acellular dermal matrices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acellular dermal matrices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.